The toxic effects of a mixture of 2-aminoanthracen e (2-AA), benzanthracen e (BA), and dinitropyrene isomers (DNP), and the toxic effects of these compound s individually, were investigated in the Fischer-344 rat following dietary exposure via a powdered basal diet. Animals were sacri ced at 14-, 30-, and 80-days of dietary exposure. Exposure to dietary 2-AA alone induced anorexia, cachexia, variable mortality, and altered serum chemistry pro les in the F-344 rat. Reduced lymphocyte counts were also shown in rats exposed to 2-AA. A temporal pattern of effect of 2-AA dietary exposure was observed in the progression of hepatic lesions in exposed animals. Dietary exposure to either DNP isomers or BA at a 10-fold higher concentration in the diet, relative to 2-AA, did not induce detectable toxic responses.
INTRODUCTION
At the turn of the century, studies in humans showed that polycyclic aromatic hydrocarbons (PAHs) are causative factors in the development of cancer (5, 34, 49) . The incomplete combustion of fossil fuels results in the formation of PAHs, both substituted and unsubstituted, and increased use of fossil fuels has elevated environmental PAH concentrations to which humans are exposed, especially near urban areas (26, 45) . Of the 54 or more PAHs identi ed at one or more National Priority List (NPL) hazardous waste sites, anthracene-and pyrene-based PAHs are among the most abundant (55) .
The aromatic amines represent another class of chemicals recognized as human carcinogens and are known or suspected of causing bladder cancer in humans (46) . Arylamines are found in tobacco smoke, synthetic fuels, agricultural chemicals, and the dye industry, often in association with PAHs (15, 48, 57) . 2-Aminoanthracene (2-AA) is a potent carcinogenic aromatic amine with its most unusual characteristic being its speci city for epithelial tissues of different animal species. Although the carcinogenic and mutagenic properties of 2-AA and the PAHs are recognized, little information is available on their possible in vivo metabolic interactions relative to each other in mammals.
Benz[a]anthracene (BA) is a prototype of the unsubstituted PAHs and is a prevalent environmental contaminant. In fact, approximately 41% of contaminated sites contain this compound. BA is considered a moderate to relatively weak carcinogen. The dinitropyrenes (DNP), which are substituted PAHs, are mutagenic compounds associated with diesel exhaust. Diesel emissions are known to induce tumors in experimental animals, and epidemiological data suggest an association between exposure to diesel exhaust and the induction of lung and bladder cancer in humans (24, 25, 46, 62, 66) . Since the nitro groups of aromatic compounds can be biochemically reduced to the amine derivative via nitroreductase enzymes present in gastrointestinal tract bacteria, they are interrelated through metabolism to aromatic amines and may contribute to the increased incidence of bladder tumors in individuals exposed to diesel exhaust (43, 62) .
Although the signi cance of anthracene-and pyrene-based PAHs with regard to environmentally caused diseases and cancer in humans is dif cult to estimate, it is suggested that the potential hazard of environmental exposures to PAHs may be underestimated (20) . The major source of human exposure to environmental PAH contaminants on a daily weight basis is from the diet (64) . This exposure pathway is consistent with a large pool of epidemiological data linking the incidence of human cancer (20-50%) and disease with dietary factors (4, 10, 37, 38, 56, 63, 65) . Other general and speci c studies have supported this view (38, 47, 70) .
The vast majority of studies conducted on the toxic properties of PAHs have focused on the effects of individual compounds (3, 16, 28, 44, 61) . These studies have provided valuable insights into potential events at the molecular level and a comparative measure for their toxicity. However, PAHs and many aromatic amines are ubiquitous environmental contaminants and generally occur as complex mixtures, rather 333 0192-6233/01$3.00 $0.00 than as pure compounds (41, 58) . Therefore, human exposure usually involves concurrent or sequential contamination with exposure amounts of up to several thousand micrograms per day depending on the compound, source, lifestyle factors, environmental food chain, and socioeconomic status (2) . The mechanisms of the toxic action and biological consequences of human exposure to PAHs and aromatic amines in mixtures are, thereby, largely dictated by the interactions of the chemicals rather than the isolated properties of individual components (8, 33) . In this regard, the current studies were conducted to evaluate the toxic effects of oral ingestion of three classes of aromatic compounds, namely, selected anthracene (benz[a]anthracene) and substituted pyrene-based PAHs (DNP isomers) and the aromatic amine 2-AA as individual compounds and as sole components of a mixture in the Fischer-344 rat model.
MATERIALS AND METHODS

Chemicals
The 2-AA (98-99% purity) was obtained from Aldrich Chemical Company, Inc (Milwaukee, WI) and BA (99.0% purity) was obtained from Sigma Chemical Company (St. Louis, MO). An isomeric mixture of 1,3-, 1,6-, and 1,8-DNP were synthesized in this laboratory. Basically, the nitration of pyrene (Sigma, St. Louis, MO) was carried out using an acetic anhydride-nitric acid system under controlled heat conditions. The nitrated pyrene products were analyzed by HPLC and consistently yielded less than 5% 1-nitropyrene (%/wt) and 95% DNP as 1,3-, 1,6-, and 1,8-DNP with yields of 18%, 35%, 42%, respectfully (%/wt). The DNP used throughout these studies refers to this composite mixture of 1-nitropyrene, 1,3-, 1,6-, and 1,8-dinitropyrenes at 5%, 18%, 35%, and 42%, respectively.
Diet Preparation
A basal semipuri ed diet (AIN-93M) was prepared using ingredients according to the 1993 formulation recommendations of the American Institute of Nutrition (1). In brief, dietary ingredients consisting of puri ed, high nitrogen casein (ICN, Costa Mesa, CA); corn starch (ICN); alphacel (ICN); dextrinized corn starch (ICN); tert-butylated hydroquinone (ICN); L-cystine (ICN); AIN-93M mineral mix (Harlan Teklad, Madison, WI); AIN-93M vitamin mix (Harlan Teklad); choline bitartrate (Harlan Teklad); and sucrose were mixed in a commercial food mixer. The prescribed amount of soybean oil (ICN) was added and mixing continued until a homogeneous mixture was obtained. The basal diet was prepared in 5-kg batches and stored at 20 C. The basal diet served as the control diet. Adulterated diets were prepared by incorporation of the speci ed PAH test compound(s) into the basal diet at the concentrations described below. Incorporation of the test compound(s) into the basal diet was accomplished by blending on an electric bottleroller bar assembly for 3 hours at room temperature in amber jars. Adulterated diets were prepared fresh on a weekly basis, aliquoted in kilogram batches, and stored at 20 C until fed to the animals. Preliminary acute studies established the concentration of the selected PAH compounds which were either nonlethal or had the potential to cause marginal lethality in chronic studies. The level of test compound(s) incorporated into the basal diet was the maximum tolerated level of each compound established in the acute study (data not published).
Animals
Male Fischer-344 rats (4-6 weeks of age) were obtained from the Division of Laboratory Animal Medicine, School of Veterinary Medicine, Louisiana State University. Animals were housed in individual hanging stainless steel wire mesh cages in a facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International (AAALAC, Int). Rats were housed under controlled conditions with a 12-hour light/dark cycle and provided water and diet ad libitum. The studies conducted for these experiments complied with the Guide for Care and Use of Laboratory Animals (42) and were approved by the Institutional Animal Care and Use Committee, and the Chemical Safety Committee of Louisiana State University.
Experimental Design
The experiment was performed in 2 stages. In the rst stage, individual compound adulterated diets were prepared for DNP, BA, and 2-AA at dietary concentrations of 0.1%, 0.1%, and 0.01% by weight, respectively. In addition, an adulterated diet was prepared as a mixture (MIX) of DNP, BA, and 2-AA with each compound represented at the same level as the individual compound diets. Lastly, unadulterated basal diet, subjected to the same bottle-roller assembly treatment and storage conditions as the adulterated diets, served as a control. Five groups of 20 male rats each were randomly assigned to the control diet or to one of the adulterated diets containing individual compounds or the mixture. Animal body weights and daily food consumption were monitored weekly on individual rats throughout the study. After 14 days and again after 30 days of continuous diet administration, 5 animals in each group were euthanatized by asphyxiation with CO 2 . After 80 days of continuous diet administration, the remaining 10 animals in each group were similarly euthanatized. The order of sacri ce was random with respect to treatment groups.
In the second stage of the experiment, an additional 3 groups of 5 rats each were fed diet containing 2-AA at 0.0075% or 0.0050% for 80 days. The remaining group was fed the control diet. At 80 days, these rats were euthanatized as described previously.
Necropsy Procedures
At the time of euthanasia, blood was collected from the abdominal vena cava posterior to the pancreas, into sterile Vacutainer brand SST gel and clot activator tubes (Becton Dickinson, Franklin Lake, NJ), and serum prepared for clinical chemical and hematological evaluations. Serum samples were prepared by allowing the blood samples to clot at room temperature for 15 to 30 minutes. Samples were centrifuged for 10 minutes at 2,000 g. Automated procedures (Olympus Reply, Olympus American, Inc, Lake Success, NY) were used to determine serum chemistry proles for the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and glucose. Additionally, at the time of euthanasia, blood was collected from the inferior vena cava distal to the pancreas, preserved in ethylenediaminetetraacetic acid (EDTA) and processed for routine hematologic evaluation.
The spleen was aseptically removed, weighed, approximately 0.1 g of distal end sectioned, the organ minus section weighed, and the organ placed on ice in a 15-ml centrifuge tube containing phosphate-buffered saline (PBS) with 5% (v/v) fetal bovine serum (FBS). Similarly, the liver and thymus of rats were excised, weighed, and sectioned, as were the lungs, kidneys and bladder. Portions of these and other organs were xed in 10% neutral-buffered formalin for 24 hours. Formalin-xed, paraf n embedded tissue blocks were cut to 5 microns and sectioned on albumin-coated slides. The slides were processed routinely and stained with hematoxylin and eosin (H&E). Sections were then cleared and mounted with nonaqueous coverslip resin (Permount, Fisher Scienti c, Cincinnati, OH).
Lymphocyte Isolation and Treatment
Single-cell lymphocyte suspensions were prepared by teasing the spleen apart in PBS with 5% FBS. The spleen was rst placed in a culture dish (Costar, Cambridge, MA) and was minced with the scissors action of 2 surgical blades and then gently mashed between the frosted ends of 2 glass slides. Cell debris was allowed to sediment and the lymphocytes were depleted of erythrocytes by use of a red blood cell lysis buffer (Sigma) followed by 2 washes in PBS with 5% FBS. Lymphocytes were resuspended in 10-ml RPMI-1640 complete media, which contained antibiotic/antimycotic (GIBCO; 100 units/ml penicillin and streptomycin and 0.25 l g/ml fungizone), 2 mM L-glutamine (GIBCO), 25 mM Hepes (GIBCO), 2 mM sodium pyruvate (GIBCO), 50 l M b -mercaptoethanol, and 10% fetal bovine serum (FBS; Sigma). Spleen cell enumeration and viability were assessed by trypan blue exclusion in a hemocytometer. Spleen cell numbers were divided by the weight of the organ minus the section and multiplied by the whole organ weight to obtain cell number/total spleen.
Statistical Analysis
The data were analyzed by 2-way analysis of variance (ANOVA) using SAS. The procedures used to test for signi cance among the main treatment effects was the General Linear Model (GLM), and to test for signi cant differences between treatment groups and the parameter the Tukey-Studentized multiple comparisons test was applied. The univariate and frequency procedures were employed to obtained information about the distribution of these parameters among the different treatment groups. Weight and intake data was analyzed using a repeated measures design and differences between groups were determined using a Tukey-Studentized multiple comparisons test.
RESULTS
Where appropriate, the 2 stages of this experiment were considered together. For statistical purposes however, they were treated separately, as warranted by slight differences in starting ages and weights of rats in the 2 stages of the experiment.
Cage side observations of untreated and treated rat indicated that animals readily consumed the control, 0.0050% 2-AA, DNP isomers, BA, or MIX-adulterated diet throughout the 80 days of the study. Neither mortality nor overt signs of toxicity were observed during the period of diet administration for these concentrations or compound examinations. In contrast, a gradual decline in general healthiness was detected in rats fed 0.0075% or 0.01% 2-AA. Indeed, rats fed 0.01% 2-AA experienced 30% mortality, culminating in the 10th week of study.
Body weights of rats exposed in the rst stage of the experiment to the individual PAH compound classes or the mixture are shown in Figure 1 . There were no differences in the initial body weights of rats in any group. There were no differences in mean body weights of rats following ingestion of DNP isomers-or BA-adulterated diet when compared with control animals at any time-point during the 80-day study period. However, when 2-AA fed rats and control rats were compared, a signi cantly lower mean body weight was detected in 2-AA fed animals from the 3rd week of the study until termination at the 11th week of the study. A signi cantly lower mean body weight was also detected in rats fed the MIX diet versus the untreated control group from the 6th week of study until termination at the 11th week. Likewise, beginning in week 2 of the second stage of the experiment, rats fed 0.0075% 2-AA experienced signi cant decrease in body weight gain relative to control rats (data not shown).
Daily diet intake, in general, paralleled the observed differences in animal body weight. No differences in dietary intake were detected for rats fed DNP isomers or BA when compared with their respective untreated control groups. Beginning at week 2, a signi cantly lower amount of food intake was detected for rats fed 0.01% 2-AA when compared with untreated controls. Daily dietary intake in the 2nd week of study was 12.06 g for 2-AA rats and 15.16 g for control rats. Daily dietary intake for rats fed 0.01% 2-AA reached a minimum (9.04 g) at 10 weeks. Daily dietary intake for rats fed the MIX (12.37 g) were only less than for controls (15.20 g) at week 11 of the study. Furthermore, when relative intake (intake/kg body weight) was calculated, no differences were detected at any week regardless of diet treatment. Therefore, although animals ingesting 2-AA for 80 days showed significantly reduced intake levels, these values were proportional to reductions in weight gain. Similar reductions in dietary intake were observed in rats consuming 0.0075% 2-AA in weeks 7 and 8 of the second stage of the experiment. However, once relative intake was calculated, intake was proportional to weight. Splenic lymphocyte counts are presented in Figure 2 . Ingestion of 0.01% 2-AA for 80 days signi cantly decreased the number of spleen cells obtained from treated rats. Exposure of rats to other compounds for less than 80 days did not alter splenic lymphocyte counts when compared to controls.
Hepatotoxicity was observed in rats exposed to 2-AA. These effects were absent or substantially reduced in rats exposed to DNP, BA, or the MIX. As shown in Figures 3  and 4 , signi cant increases in absolute and relative liver weights were observed in rats fed 0.01% 2-AA for 80 days. Increases in relative liver weights were also observed for rats fed the MIX, but were much less than for rats fed 2-AA alone. Serum levels of AST and ALT were assayed in rats fed DNP isomers-, 2-AA-, BA-, or MIX-adulterated diet for the 14-, 30-, and 80-day time periods and compared to values of the same time-point detected in untreated control animals ( Figures 5 and 6 ). The mean AST levels were signi cantly elevated by ingestion of 0.01% 2-AA-adulterated diet by rats at both the 14-and 80-day subsamples. There were no differences in mean AST levels of rats ingesting DNP isomers-, BA-, or the MIX-adulterated diet when compared with untreated control rats at any subsampling time-point. Similar ndings were obtained for serum ALT. When 2-AA was incorporated for 80 days into diets at 0.005% and 0.0075%, only rats fed 0.0075% 2-AA had elevated AST (but not ALT) levels (data not shown).
Hematologic examination revealed that, although differences were detected in pack cell volume, there was a general lack of consistent alterations in blood cell volume, blood cell count, or differential cell count. Furthermore, detected values of each of the different clinical parameters examined did not appear to vary by duration of adulterated diet ingestion. Compared with a compilation of published hemograms for the rat, all clinical parameters were within the published normal ranges for rats. Morphological examination of rat tissues provided some insight into the extent and nature of 2-AA toxicity. No obvious tumors were observed in untreated animals or in animals constantly maintained on a PAH-adulterated diet. However, the liver from rats fed 0.01% 2-AA for 80 days were not normal. Visibly evident and numerous nodules were observed on the parietal and visceral surfaces of livers from 2-AA exposed animals. As shown in Figure 7 , hematoxylin-and eosin-(H&E) stained tissue sections of rats fed the untreated or a PAH-adulterated diet were examined for pathology. Histological examination revealed a marked treatment and temporal response in hepatotoxicity by ingestion of 2-AA-alone-adulterated diet and an attenuation of these effects by the MIX. In an untreated control liver lobule (A), hepatocytes appear homogeneous and are arranged in radiating plates about the central vein. By contrast, in the development of liver toxicity, new altered cell populations often appear, and these new hepatocyte populations function TOXICOLOGIC PATHOLOGY as sites of origin for yet another altered hepatocyte population. Following 14 days of ingestion, evidence of altered hepatocyte populations were observed in liver sections from 2-AA-alone-exposed rats (B). The liver sections of 14-day, 2-AA-alone-exposed rats also revealed hydropic changes in hepatocytes, as evidenced by clear cell foci and the presence of vacuoles, likely due to lipid accumulation. Following 30 days of ingesting 2-AA, areas of hyperplasia and distortion of hepatic lobular architecture, characteristic of focal hepatocellular hyperplasia, were observed (C). The lesions progressed to hepatocellular hyperplastic nodules that were observed in liver sections of rats that consumed 2-AA for 80 days (D). These nodules were well demarcated by compression of the adjacent tissue and by altered staining properties. In addition, a loss of normal lobular architecture, and nodules within nodules were observed. On the other hand, following 80 days of ingestion of the MIXadulterated diet, which contained 2-AA at the same dietary level as the 2-AA-alone-adulterated diet, liver sections of rats showed only a small number of altered foci of clear cells or cytoplasmic vacuoles (E). These alterations were essentially similar to those in Figure 7B . Rats fed 0.0075% 2-AA alone (but not 0.005%), for 80 days also developed circumferentially compressed hepatic hyperplastic nodules, though the degree of nodule formation was less than for rats fed 0.01% for 80 days (not shown). Hepatic lesions were not observed in H&E stained liver sections of animals exposed to DNP isomers or BA or from liver sections of control animals.
Similarly, no obvious or histopathologica l lesions were observed for the lungs or bladders of the animals from any of the study groups. However, histopathologic alterations were observed in the kidneys of rats exposed to 2-AA (0.01%) for 80 days. Lesions consisted of distention of the proximal tubules and occlusion of tubules with protein casts. No histological lesions were observed in the kidneys of rats in any other groups.
DISCUSSION
Humans and animals are rarely exposed to individual compounds in the environment. More often, they are exposed to combinations of compounds, either concurrently or sequentially, which can have differing effects on individual cells and organ systems (56) . The interactions of differing compounds can in uence toxicity of individual compounds. The interactions of compounds in a mixture may potentiate the response (a synergistic response), may inhibit the response (an antagonistic response) or, less likely, produce an additive effect (an independent response). The interactions of differing compounds can affect the metabolism or disposition of a given compound, altering absorption and/or distribution. Examples of such interactions include the decrease in renal excretion of penicillin when co-administered with probenecid (40) .
This study investigated the potential toxic effects of 3 different classes of aromatic compounds-nitroarenes, arylamines, and alternate aromatics, when administered in the diet as individual compounds and when administered concurrently as a composite mixture. Although numerous studies have evaluated these and other similar compounds individually for their biological effects, few studies have investigated their effects following ingestion. In addition, fewer studies have simultaneously examined the effects of subacute or subchronic ingestion of individual compounds along with the interactive effects of the same compounds when administered concurrently as components of a mixture.
Administration of BA or DNP Alone
The results of this study clearly indicate that the toxicity of the dinitropyrene isomers and of 1,2-benz[a]anthracene is minimal when administered in the diet individually for up to 80 days at concentrations of 0.10%. Although decreases in feed intake were observed, no decrease in body weight, no mortality or adverse effects in general health of animals ingesting DNP isomers-or BA-adulterated diet were detected. Morphological examination of tissues at necropsy failed to reveal gross abnormalities. These results differ from the reports of others. Intragastric administration of BA to rats at 100 mg/kg/day for 4 days was shown by Torronen et al (67) to induce cytosolic anti-diuretic hormone levels and increased relative liver weight in exposed animals by 19% when compared with untreated control animals. In another study, the induction of foci of altered hepatocytes was shown following a single intragastric administration of 180 mg/kg benz[a]anthracene to rats followed by a diet containing 2-acetylamino uorene and carbon tetrachloride (69) . Unfortunately, we found no studies in the literature that examined dietary exposure to BA or DNP isomers in mammalian systems, and a direct comparison of these cited studies with the present study is problematic, because the route of exposure and experimental protocols differ signi cantly. A previous study in this laboratory, which examined the metabolic distribution and excretion of DNP isomers and BA (data not shown) showed that both the dinitropyrenes and 1,2-benz[a]anthracene were apparently only poorly absorbed from the gastrointestinal tract. Forty-eight hours following oral gavage of radioisotope-labeled dinitropyrenes or benz[a]anthracene, 89.6% and 74.7%, respectively, of the recovered labeled compound was detected in fecal excreta. The fecal contents were not examined for parent compound-only for radioactivity. Therefore, although the fecal contents accounted for a signi cant amount of the recovered labeled compound, whether the feces represented compound metabolized by the liver and excreted in the bile or compound simply not absorbed was not determined. Thus, a possible lower absorption rate from the gastrointestinal tract may account for the lowered toxicity shown in this study compared with studies demonstrating a toxic response in rats and mice following either injection or direct instillation of these compounds into the animal.
Administration of 2-AA Alone and in Combination with BA and DNP
In contrast to the lack of toxic responses in rats following the 80 day DNP-or BA-adulterated diet administration, a dose-dependent and temporal progression of toxic effects following dietary exposure to 2-AA was demonstrated by this study. Furthermore, a ternary mixture composed of 2-AA, DNP isomers, and BA was shown to attenuate the toxic effects of 2-AA, suggesting that one or more components in the mixture may have 1) suppressed the activation of 2-AA to its ultimate cytotoxic or genotoxic metabolite; 2) inhibited uptake of 2-AA; or 3) competed with 2-AA or a metabolite for cellular binding sites. Although de nitive studies were not undertaken here to determine the role of each of these parameters, these conclusions were supported at several levels of investigation.
Firstly, observational data along with intake and bodyweight data indicated temporal and dose responses in toxic effects by ingestion of 2-AA when included in the diet at concentrations ranging from 0.005% to 0.01%. In animals fed diet containing 0.01% 2-AA, a premature mortality of 30%, and overt signs of morbidity, anorexia, and cachexia were observed. Decreases in body-weight gain and diet intake showed signi cant deviations from control animals at the end of 3 weeks. On the other hand, rats fed the MIXadulterated diet, which contained 2-AA at the same level of dietary concentration (0.01%), did not exhibit obvious signs of toxicity and anorexia, and premature mortality was not observed. Although weight gain was slowed by ingestion of the mixture, weight differences were not detected until the 6th week of diet ingestion. Since the concentration of 2-AA in the mixture was the same as 2-AA in the individual diet, differences in intake could not be accounted for by differences in palatability.
Secondly, a comparison of clinical chemistry data between 80-day 2-AA-alone-treated and control-, or MIX-treated rats indicated signi cant elevations in the serum enzyme levels following 80 days of dietary administration of 0.01% (AST and ALT) and 0.075% (AST) 2-AA to rats. Differences in these enzyme levels were not detected following 80 days of dietary administration of the mixture, nor following lower concentrations or shorter duration of administration of 2-AA. Aminotransferases are widely distributed in body tissues; however, the greatest concentrations of aspartate aminotransferase (AST) are found in the heart, liver, and kidneys, while the highest levels of alanine aminotransferase (ALT) are found in liver and kidneys (18) . Tissue destruction leads to the release of these intracellular enzymes into the circulating blood. Whereas both are good indicators of hepatic damage, elevations in AST and ALT are not speci c for hepatic damage. Serum activity of these enzymes can be elevated in other disease conditions (12) . Also, Cornelius (11) found a relationship between body size and hepatic ALT activity. The smaller the animal is within the weight range studied, the greater the ALT activity. The rats ingesting 2-AA (0.01%) for 80 days demonstrated signi cantly reduced body weights compared to the untreated control rats. Therefore, elevated ALT activities in 2-AA fed rats could have been in uenced by reduced body weight.
Thirdly, reduced lymphocyte numbers suggested a potential immunosuppressive effect of dietary exposure to 2-AA. However, a distinction must be made between immunosuppression and cytotoxicity (13) . Several classes of chemical agents and some drugs are known to be cytotoxic to lymphocytes (6) . Other studies using the rodent model have shown that exposure to PAH compounds signi cantly suppressed the-B-cell mediated humoral immune response and produced dose-dependent suppression of the lymphoproliferative response to the B-cell mitogen LPS (14, 53, 71, 72) .
The activation of primary aromatic amines, as a class, typically requires oxidation of the amine group to the N -hydroxy moiety (31) . Hammons et al (21) showed that the oxidation of the functional amino group of several arylamines is catalyzed primarily by cytochrome P4501A2 (CYP1A2), a reaction which does not take place in lymphocytes because CYP1A2 is not expressed in extrahepatic tissue (45) . In the rat, however, metabolic N -oxidation of certain primary amines, such as 2-AA, can be performed by intestinal micro ora (45) . The hydroxylamines show some reactivity to DNA at slightly acidic pH values, and are directly mutagenic and carcinogenic (31, 27, 36) . The protonated hydroxylamine may be converted by spontaneous hydrolysis to water and an aryl nitrenium ion, which may be the electrophilic metabolite that results in cytotoxicity (52) .
It is known that 2-aminoanthracene is a potent carcinogen and is one of the few aromatic amines found to induce hepatomas and skin tumors (35, 60) . A decrease in liver weight at 14 days followed by a progressive increase in weight at 80 days in rats exposed to 0.01% 2-AA was suggestive of toxic liver insult, while the absence of such effects in rats exposed to the mixture of compounds was suggestive of attenuation of these effects. Chemically induced rodent hepatocarcinogenesis is thought to progress from normal hepatocytes through histologically identi able hepatocellular lesions and nally to neoplasms (17) . The classi cations of hepatocellular lesions are marked by distinct histologically identi able alterations that differ in severity of toxic injury. A temporal progression of hepatocellular lesions was detected in liver sections of rats following dietary administration of 2-AA alone, whereas lesions of less severity were detected in liver sections of rats following 80 days of dietary administration of the aromatic compound mixture. Foci of cellular alteration following 14 days of dietary administration, which progressed to focal hepatocellular hyperplasia following 30 days of dietary administration and on to hepatocellular adenomas following 80 days of dietary administration were observed in rats consuming 0.0075% and 0.01% 2-AA-alone-adulterated diet. On the other hand, only foci of cellular alterations were observed in rats that were administered the mixture of PAH compounds.
The aim of the present study was to investigate whether, and to what degree, a mixture of 3 classes of aromatic compounds would alter the toxic effects of the individual components of the mixture. To this end, rats ingested powdered diet containing either an individual component or the mixture for a period of 80 days. The classes of aromatic compounds and selected representatives included the nitroarenes, represented by the dinitropyrenes, arylamines represented by 2-aminoanthracene, and the alternate aromatic compounds represented by benz[a]anthracene. Only the arylamine, 2-aminoanthracene, exhibited toxic effects, as measured by the parameters of this study. Ingestion of the mixture attenuated the toxic effects of 2-AA and the results of this study suggest a toxicokinetic mechanism. The activation of arylamines involves N -hydroxylation by microsomal cytochrome P-450, notably the hepatic speci c P-4501A2, and O-acetylation of the N -hydroxylated products by cytosolic transferases (9, 19, 29, 32) . Considerable interindividual variation both in the level of hepatic expression and in the rate of metabolism of CYP1A2 substrates have been reported (30) . Phenotyping studies have suggested that three phenotypes of the CYP1A2 gene may be distributed among the human population-slow, intermediate, and rapid metabolizers; and that considerable variation in the distribution of these phenotypes is seen in individuals of different racial/ethnic groups (30, 62) . For example, induction of CYP1A2 by cigarette smoking was shown in Caucasians but not in Chinese or in African-Americans (7, 30) . The initial N -hydroxylation step is followed by O-acetylation (73) . It has been hypothesized that the hydroxylamine is acetylated to form the ultimate carcinogen, and hepatic cytosol contains N -acetyltransferase enzymes that can O-acetylate (59, 68) . Humans and most other mammalian species express a genetic polymorphism in N -acetylation capacity that segregates individuals of each species into rapid, intermediate, or slow acetylators (22) . Rats in general, and the Fischer-344 inbred rat in particular, are often utilized to study the toxicity and carcinogenicity of aromatic amines (50) . This is because the inbred rat mimics the polymorphism in Nacetylation capacity exhibited in humans (23, 39) . The N -acetylation polymorphism is of both clinical and toxicological importance because rapid or slow acetylator phenotype can in uence the toxic response from aromatic amines (51) .
The nitroarenes, such as the dinitropyrenes, are activated via reduction by micro ora in the gastrointestinal tract to N -hydroxyarylamines and subsequently by O -acetylation of the N-hydroxylated products by cytosolic transferases (54) . Thus, the dinitropyrenes and arylamines may share common pathways of metabolism to ultimate carcinogens and may compete with each other for the same activating enzymes (33) . The mixture of PAH compounds contained 2-AA: DNP:BA at concentrations of 0.01%:0.1%:0.1% , respectively. Thus, the dinitropyrenes were represented at a 10-fold greater concentration than 2-AA. It is likely that the 10-fold greater concentration of the dinitropyrenes in the mixture successfully competed with 2-AA for acetylation, thereby conferring an attenuating effect with the mixture. Further support for this hypothesis comes from studies that show that the N -acetylation polymorphism is expressed similarly in the liver and pancreas of inbred rats (39) .
Further exploration at the biochemical level, utilizing the tools of molecular biology, may help to elucidate the basis of the association between dinitropyrenes and 2-AA. Further study is also needed to examine the association of 2-AA with other arylamines. Nonetheless, the results of this study demonstrate the importance of examining multiple tissues in an integrated organism in order to evaluate the interactions of compounds in mixtures. These data also bring into question the interpretation of toxicological and pathological data generated from the examination of exposures to one compound at a time, especially where actual exposures may occur as mixtures.
